Share Name Share Symbol Market Type Share ISIN Share Description
Hvivo Plc LSE:HVO London Ordinary Share GB00B6ZM0X53 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 14.75 14.50 15.00 14.75 14.75 14.75 0.00 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 11.0 -18.9 -21.3 - 12

Hvivo Share Discussion Threads

Showing 2701 to 2724 of 2725 messages
Chat Pages: 109  108  107  106  105  104  103  102  101  100  99  98  Older
DateSubjectAuthorDiscuss
01/11/2019
08:41
wheres that bernymadoff poster who was always ramping this cr@p ? Probably has multiple ids
mister md
25/10/2019
15:03
Nothing happening IMO unfortunately. For those interested in alternative Pharma stocks (if you're not, no problem - this is a shameless plug) Open Orphan AIM:ORPH is one I’d recommend keeping an eye on - Share price has performed well over the last 6 months and it's no surprise - CEO Cathal Friel predicts 40% growth a year on podcast below with 2 million of his own money invested. hxxps://audioboom.com/posts/7361662-open-orphan-orph-ceo-cathal-friel-tells-alan-green-why-he-expects-40-percent-growth-year-on-year Their health databank a standout for me and is progressing well. ORPH recently signed an agreement with Empiric Logic, a leading managed software service company. The Collaboration is the final stage in the completion of Open Orphan’s Genomic Health Data platform and will speed up its launch. The companies CCO Maurice Treacy is holding a live webinar on Wednesday 30th October 2019 at 19:00 (UK time) for those interested: hxxps://vtm.clickmeeting.com/orph
sunningdale1
20/10/2019
14:40
#HVO Equity Income Fund was suspended in June. Companies such as #Tissue #Regenix, #Synairgen, #Arix ... https://thismon.ee/a/7591003 via @ThisIsMoney
newtothisgame3
19/10/2019
08:55
Start of the decline.No sign of an update and cancelled contracts.
mertymcs
18/10/2019
20:56
THIS IS ONLY THE START YOU MUGS !
therealapplegarth
17/10/2019
13:01
Well this is looking like a dead fish now. Cannot even get in contact with anyone at the company to ask investor questions to.
mertymcs
16/10/2019
16:49
But note the RNS wording "No trading in the stock - voting control interest over stock transferred to new manager". This RNS wording is the same as several other WEIF companies.Yesterday's letter said both Blackrock and Park Hill are handling different segments of the ex-WEIF portfolio. And today he has quit managing his other two funds.Opportunity: In amongst this overhung wreckage are there some gems to look out for....... Did Woodford's team get it right occasionally?!Cheers, tightfist
tightfist
16/10/2019
09:09
Looks like you were wrong "Applegarth", nothing new there then
discojames
16/10/2019
05:58
Wait till woodys holding here is dumped into the markets ! SUB 2p in sights. FVCK you spurs777
therealapplegarth
15/10/2019
20:31
All Woody funds being closed and put into run down over time. Not sure where his 18% or 15M shares are held but happy to see the back of him.
loafofbread
10/10/2019
21:36
Maybe this is why the U.S. want to spend $130million developing a universal flu vaccine? hxxps://www.nytimes.com/2018/08/27/health/china-flu-virus-samples.html
muchodinero
30/9/2019
10:59
hxxps://www.federalregister.gov/documents/2019/09/24/2019-20804/modernizing-influenza-vaccines-in-the-united-states-to-promote-national-security-and-public-health
muchodinero
24/9/2019
15:32
That's one thing we agree on, hoping Trevor will leave soon as he's been a real dissappointment with the handling of an asset like flu v and general shareholder contact and updates. Could do with a new head and a PR person/team. Hopefully a new CEO would be better at negotiation or have the foresight to bring in someone that is, but then again it could all be led by Seek - hvivo could be as frustrated as we are about the whole thing
discojames
24/9/2019
08:06
think you're more likely to see see director byes than director buys
mister md
20/9/2019
15:40
Did I miss the director buys?
loafofbread
19/9/2019
16:11
because every share has that comment
babbler
19/9/2019
11:52
why is that Babbler?
tonyw99
19/9/2019
11:51
Disco - they've spent that. Cash received from R&D credit on 4th Sept. Cash balance on the 6th £4.3m. Net inflows of £0.3m from July to Sept means outflows of £1.3m without the R&D rebate. They expect cash outflows throughout H2 and no booked work for H1 20
tonyw99
19/9/2019
11:29
the going concern comments from people on shares always makes me smile.
babbler
19/9/2019
11:25
Not quite true, they also made a net profit for that period of £0.3m (highly significant they are beginning to move to profit in my opinion), and have an R&D grant of £2.4m on top of that, so cash should be around £6.7m
discojames
19/9/2019
11:09
They are close to running out of cash and they know it £4.0m at 6th Sept. The going concern statement isn't glowing either.
tonyw99
19/9/2019
09:34
yup one to buy if you have more than 5 minute view.
babbler
19/9/2019
09:05
Trust the market to concentrate on the bad. All expenditure down, income up, on course for profitability in 2020 even with the failed contract which is beyond Hvivo control.
discojames
19/9/2019
08:25
results weren't that bad. Losses down revenue up profitability next year. MMS concentrated on late contract cancellations. Despite that losses are down and margins up.
babbler
Chat Pages: 109  108  107  106  105  104  103  102  101  100  99  98  Older
Your Recent History
LSE
HVO
Hvivo
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191122 18:19:15